Buck Institute receives $3.5 million federal grant to lead clinical trial of ketone intervention in older adults

The Buck Institute for Research on Aging has received a $3.5 million federal grant to lead the first-ever double-blind, randomized, placebo-controlled clinical trial to understand the effects of ketone ester supplementation on frailty, a condition of vulnerability which develops following age-related decline in multiple physiological systems.

How many patients could benefit from custom genetic therapies? Timothy Yu narrows in on an answer

Timothy Yu sent shockwaves through the genetic therapy world four years ago after revealing that he had developed — in under a year — a

July 13, 2023

Pharmalittle: We’re reading about rescinded FDA firings, Trump tariff warnings, and more

Good morning, everyone, and welcome to another working week. We hope the weekend respite was refreshing and reassuring. After all, that oh-so familiar routine of

February 24, 2025

Does cannabis use impact the risk of glaucoma? New study investigates

The study in Scientific Reports finds no significant association between cannabis use and the risk of primary open-angle glaucoma, challenging the notion that cannabis could

November 14, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.